Core Insights - Pharmaceutical companies are facing increasing pressure to reduce drug prices in the U.S. market [1] - Novo Nordisk is experiencing challenges due to competition in its weight loss treatment sector [1] - To enhance its drug pipeline, Novo Nordisk is considering making an acquisition [1]